Go Pro
OTCMKTS:MKGAF

Merck KGaA (MKGAF) Stock Price, News & Analysis

Merck KGaA logo
$166.60 +2.89 (+1.77%)
As of 09/3/2026 03:53 PM Eastern

About Merck KGaA Stock (OTCMKTS:MKGAF)

Advanced

Key Stats

Today's Range
$157.43
$166.60
50-Day Range
$153.28
$174.77
52-Week Range
$116.68
$175.56
Volume
470 shs
Average Volume
602 shs
Market Capitalization
$21.53 billion
P/E Ratio
25.44
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses. Its Healthcare division develops and commercializes prescription pharmaceuticals and biopharmaceutical therapies across areas such as oncology, immunology and fertility, and it provides related clinical development and manufacturing capabilities. The Life Science business supplies research- and manufacturing-critical products and services to academic, biotech and pharmaceutical customers worldwide — including lab reagents, filters, chromatography media and instruments; in the U.S. and Canada this business is widely known under the MilliporeSigma name following strategic acquisitions. The Performance Materials segment produces specialty chemicals and advanced materials for electronics, display and semiconductor applications, offering materials used in consumer electronics, data centers and industrial processes.

Merck KGaA has grown through a combination of internal R&D and strategic acquisitions, notably expanding its life science footprint through the acquisitions of Millipore and Sigma-Aldrich. The company emphasizes investment in research and development, partnerships with academic and industry collaborators, and global manufacturing and distribution networks to support clients across the pharmaceutical, biotechnology and high-tech supply chains. In North America, certain pharmaceutical activities operate under the EMD Serono brand to reflect regional branding conventions.

Leadership is focused on strengthening innovation and sustainable growth; Belén Garijo serves as Chair of the Executive Board and CEO, bringing experience from the company’s healthcare operations. Merck KGaA’s diversified mix of pharmaceuticals, life-science tools and performance materials positions it as a broad-based supplier to both healthcare and high-tech industries with a global footprint and long history of scientific activity.

AI Generated. May Contain Errors.

Receive MKGAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MKGAF Stock News Headlines

This sub-5 dollar stock operates next to SpaceX and Blue Origin
A small public company trading under $5 a share operates inside the secure perimeter of Kennedy Space Center, right alongside SpaceX and Blue Origin. It holds a special agreement to use a multi-billion dollar federal launch facility for just $500, and its customer list already includes the Pentagon, Lockheed Martin, and GE Aerospace. Most Wall Street analysts have not caught on yet, but a major milestone could change that soon.tc pixel
See More Headlines

MKGAF Stock Analysis - Frequently Asked Questions

Merck KGaA's stock was trading at $147.60 at the beginning of 2026. Since then, MKGAF stock has increased by 12.9% and is now trading at $166.6010.

Top institutional shareholders of Merck KGaA include Bank of America Corp DE (23.63%), Legal & General Group Plc (14.60%), Barrow Hanley Mewhinney & Strauss LLC (5.67%) and Caisse de depot et placement du Quebec (3.44%).

Shares of MKGAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
9/04/2026
Next Earnings (Estimated)
11/12/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:MKGAF
CIK
N/A
Employees
62,908
Year Founded
1891

Profitability

EPS (Trailing Twelve Months)
$6.81
Trailing P/E Ratio
25.44
Forward P/E Ratio
17.09
P/E Growth
N/A
Net Income
$3.06 billion
Net Margins
12.60%
Pretax Margin
15.64%
Return on Equity
10.17%
Return on Assets
5.74%

Debt

Debt-to-Equity Ratio
0.27
Current Ratio
1.31
Quick Ratio
0.84

Sales & Book Value

Annual Sales
$22.72 billion
Price / Sales
0.95
Cash Flow
$50.18 per share
Price / Cash Flow
3.32
Book Value
$212.00 per share
Price / Book
0.79

Miscellaneous

Outstanding Shares
129,240,000
Free Float
N/A
Market Cap
$21.53 billion
Optionable
Not Optionable
Beta
0.96

Social Links

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (OTCMKTS:MKGAF) was last updated on 9/4/2026 by MarketBeat.com Staff.
From Our Partners